Skip to main content

AtonRa Partners

SEC CIK
0001846445
Latest filing
Feb 5, 2024

MRNA holding history

Moderna, Inc. in every 13F filed by AtonRa Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MRNA overviewAll 13F holders of MRNAFull Q4 2023 holdings

Shares (Q4 2023)
2,446
Value
$243.3K
% of portfolio
0.5%
Quarters held
12
Since Q1 2021
Holdings of MRNA by AtonRa Partners, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20232,446$243.3K0.5%−271−10.0%ReducedHolders
Q3 20232,717$280.6K0.6%−570−17.3%ReducedHolders
Q2 20233,287$399.4K0.6%−118−3.5%ReducedHolders
Q1 20233,405$522.9K0.8%−341−9.1%ReducedHolders
Q4 20223,746$672.9K0.9%−1,013−21.3%ReducedHolders
Q3 20224,759$563.0K0.6%−142−2.9%ReducedHolders
Q2 20224,901$700.0K0.6%−4,355−47.1%ReducedHolders
Q1 20229,256$1.59M0.9%−4,482−32.6%ReducedHolders
Q4 202113,738$3.49M1.2%+69+0.5%AddedHolders
Q3 202113,669$5.26M1.8%−1,905−12.2%ReducedHolders
Q2 202115,574$3.66M1.3%−9,180−37.1%ReducedHolders
Q1 202124,754$3.24M1.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.